View Older Stories

Sep 24, 2026 12:18PM Citi cuts Acadia Pharmaceuticals price target to $33

Sep 24, 2026 12:16PM Acadia Pharmaceuticals (ACAD) PT Lowered to $34 at BMO Capital Amid Heavy Selling

Sep 24, 2026 10:02AM Acadia Pharmaceuticals drops on trial miss

Sep 23, 2026 05:24AM Oppenheimer Reiterates Perform Rating on Acadia Pharmaceuticals (ACAD)

Sep 21, 2026 06:03AM Increasing unusual option volume: UTHR ABUS OPRA GFL ACAD

Sep 15, 2026 10:01AM Increasing unusual option volume: ACAD ALHC PLAY FPS ITUB NAVN WVE UAL XEL

Sep 3, 2026 06:44AM Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)

Aug 25, 2026 06:57AM H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)

Aug 24, 2026 06:10AM EU approves Acadia's trofinetide for Rett syndrome treatment

Aug 17, 2026 06:50AM Acadia Pharmaceuticals (ACAD) PT Raised to $49 at UBS

Aug 13, 2026 06:48AM Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)

Aug 6, 2026 06:56AM H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)

Aug 5, 2026 09:16AM Acadia Pharmaceuticals (ACAD) PT Raised to $37 at RBC Capital on 'Strong Sales'

Aug 5, 2026 06:33AM Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Oppenheimer

Aug 5, 2026 04:07AM Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Citizens: Remains a Top Pick

Aug 5, 2026 12:52AM Acadia Pharma (ACAD) Tops Q2 EPS by 12c ; Offers Guidance

Jul 29, 2026 05:19AM Acadia Pharmaceuticals (ACAD) PT Raised to $14.50 at BofA Securities

Jul 20, 2026 04:25PM Acadia Pharmaceuticals (ACAD) PT Raised to $25 at Stifel

Jul 20, 2026 12:25PM Mizuho n Acadia Pharmaceuticals (ACAD): 'we view risk/reward as skewed significantly to the upside'

Jun 30, 2026 06:44AM H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)

Jun 29, 2026 07:20AM Acadia Pharmaceuticals (ACAD) PT Raised to $37 at Deutsche Bank

Jun 29, 2026 06:58AM Acadia Pharmaceuticals (ACAD) PT Raised to $36 at Canaccord

Jun 29, 2026 06:41AM Mizuho Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)

Jun 29, 2026 06:03AM Acadia Pharma (ACAD) call put ratio 6.8 calls to 1 put with a focus on July 25 calls

Jun 29, 2026 03:57AM Acadia Pharmaceuticals (ACAD) PT Raised to $35 at Citi, Opens 90-Day Upside CW

Jun 26, 2026 12:33PM Oppenheimer Reiterates Perform Rating on Acadia Pharmaceuticals (ACAD)

Jun 26, 2026 10:51AM Baird Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)

Jun 26, 2026 08:09AM Mizuho Reiterates Outperform Rating on Acadia Pharmaceuticals (ACAD)

May 7, 2026 06:29AM Canaccord Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)

May 6, 2026 04:07PM Acadia Pharma (ACAD) Misses Q1 EPS by 3c ; Offers Guidance

Apr 7, 2026 09:08AM ACADIA Pharmaceuticals launches powder formulation of Rett syndrome drug

Mar 25, 2026 06:10AM BofA Securities Upgrades Acadia Pharmaceuticals (ACAD) to Buy

Mar 24, 2026 05:54AM RBC Capital on Acadia Pharmaceuticals (ACAD): 'Setup Skews Net Favorably'

Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'

Mar 2, 2026 04:57PM Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at BofA Securities

Mar 2, 2026 04:56PM Acadia Pharmaceuticals (ACAD) PT Lowered to $29 at BofA Securities

Mar 2, 2026 04:05PM Acadia Pharmaceuticals plans re-examination after EU rejection of Rett drug

Feb 26, 2026 07:51AM Acadia Pharmaceuticals (ACAD) PT Raised to $20 at Jefferies

Feb 26, 2026 06:58AM Acadia Pharmaceuticals (ACAD) PT Lowered to $33 at Citi

Feb 26, 2026 04:37AM Acadia Pharmaceuticals (ACAD) PT Raised to $35 at Citizens: Potential for Robust Growth

Feb 25, 2026 04:16PM Acadia Pharma (ACAD) Tops Q4 EPS by 146c ; Offers Guidance

Feb 24, 2026 09:01AM Wolfe Research Starts Acadia Pharmaceuticals (ACAD) at Outperform

Feb 23, 2026 03:32PM Acadia Pharma (ACAD) call put ratio 37 calls to 1 put with a focus on March calls as share price up 1.4%

Feb 23, 2026 04:41AM Mizuho Upgrades Acadia Pharmaceuticals (ACAD) to Outperform

Feb 6, 2026 06:31AM Acadia Pharmaceuticals (ACAD) PT Raised to $23 at Oppenheimer

Feb 3, 2026 08:48AM Acadia Pharmaceuticals (ACAD) PT Lowered to $31 at RBC Capital

Feb 3, 2026 06:43AM H.C. Wainwright Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)

Feb 3, 2026 06:36AM Canaccord Genuity Reiterates Buy Rating on Acadia Pharmaceuticals (ACAD)

Feb 3, 2026 04:11AM Acadia Pharmaceuticals (ACAD) Reiterated at Market Outperform by Citizens

Feb 2, 2026 04:14PM ACADIA receives negative trend vote from EU regulators on Rett drug

View Older Stories